Postpartum Depression – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

Postpartum depression (PPD) refers to the depression that some women experience after childbirth. Very few drugs are approved to treat PPD; hence, the drugs used for major depressive disorder (e.g., SSRIs, SNRIs, mixed serotonin modulators, atypical antipsychotics) are often used off-label for PPD. The high unmet need for therapies specifically targeting PPD gives the first agent approved to treat the disorder, Zulresso (Sage Therapeutics), an opportunity to be incorporated into the PPD treatment algorithm and creates opportunities for the new oral drug Zurzuvae (Sage Therapeutics) and for future drug developers. This report provides national patient-level claims data to explore the use of key therapies in both newly diagnosed and recently treated patients, providing insight into the current PPD treatment landscape.

Questions answered

  • What patient shares do key therapies and brands garner by line of therapy in newly diagnosed PPD patients? What are the quarterly trends in prescribing among recently treated and newly diagnosed PPD patients?
  • How has Zulresso been integrated into the treatment algorithm, and what is its source of business?
  • What percentage of PPD patients receive drug therapy within one year of diagnosis, and how quickly? What percentage of patients progress to later lines of therapy within one year of diagnosis?
  • What percentage of PPD patients are treated with monotherapy vs. combination therapy? What are the most commonly used combinations?
  • What are the product-level compliance and persistency rates among drug-treated patients?

Markets covered: United States

Key companies: Sage Therapeutics, AbbVie, Lundbeck, Otsuka, Takeda, Johnson & Johnson Innovative Medicine, Axsome Therapeutics

Key drugs: Zulresso, SSRIs, SNRIs, bupropion, atypical antipsychotics, mixed serotonin modulators, tricyclic antidepressants, benzodiazepines, anxiolytics

Product description

Treatment Algorithms: Claims Data Analysis provides detailed, quantitative analysis of the treatment journey and brand usage across lines of therapy and overall using real-world, patient-level claims data so that marketers can accurately assess their source of business, benchmark usage against competitors, and quantify areas of opportunity for their marketed or emerging brand.

Key features

Dashboard featuring interactive visuals, easy navigation, and expanded analyses.

launch Related Market Assessment Reports